Antibody Detection and Monitoring Assays

Antibody screening, identification, and monitoring utilizing Luminex xMAP technology, to provide a complete testing solution to detect donor-specific antibodies (DSA), pre and post-transplant.

Driven by the Luminex xMAP platform, our C1qScreen assay provides laboratories with a reliable tool for distinguishing between complement binding and non-complement binding antibodies.

A flow cytometry-based crossmatch assay optimized for the detection of leukocyte antibodies, combining traditional flow cytometry cellular crossmatch testing with the specificity of microbeads technology.

Designed for use in flow cytometric detection, several FlowPRA test options are available to screen human sera for antibodies, assigning percent PRA and antibody specificity for HLA Class I and Class II.

Isolates specific HLA antibodies using magnetic bead panels to adsorb and elute targeted antibodies.

Anti-AT1R and anti-ETAR assays detect biomarker antibodies that form against angiotensin II type 1 receptors (AT1R) and endothelin receptors type A (ETAR).

Panels frozen lymphocytes dispensed in Terasaki trays, designed to determine PRA and HLA antibody screening by complement-dependent cytotoxicity.

Economical and convenient for screening patients, determining percent PRA and identifying antibodies. Terasaki trays are pre-coated with HLA Class I and Class II antigens designed to perform antibody detection based on ELISA techniques.